FDA device listing
EL-Glia IgA/IgG,EL-tTG IgA/IgG
FDA device listing 1770999955 · TheraTest Labs, Inc.
Key facts
| Proprietary names | EL-Glia IgA/IgG,EL-tTG IgA/IgG |
|---|---|
| Owner/operator | TheraTest Labs, Inc. |
| Owner/operator number | 1421346 |
| Premarket submissions | K071692 |
| Product codes | MST, MVM |
| Device names | MST - Antibodies, Gliadin, MVM - Autoantibodies, Endomysial(Tissue Transglutaminase) |
| Device class | Class II |
| Classification regulations (21 CFR) | 866.5660, 866.5750 |
| Review panels | Immunology |
| Registered establishments | THERATEST LABORATORIES, INC. |
| Establishment registrations | 1421346 |
| FEI numbers | 1421346 |
| Establishment operations | Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- 1–9 UDI devices (GUDID) under the same submission
- 1–9 Device listings citing the same submission
- Yes Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database